In p53-proficient GBM-SCs, FoxO3 overexpression inhibited the loss of stem and progenitor cell markers, which usually occurred upon γIR/PI-103 combination treatment in p53-proficient CSCs (Figure 6D; see also Figure 1A). This evidence concerns the gene TP53 and glioblastoma.